MedTrace Logo

Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy

NCT00165438 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2012-12-20

No results posted yet for this study

Summary

The purpose of this study is to find out the impact Bleomycin-containing chemotherapy, given with or without chest radiation therapy, on patients' lung function over time.

Conditions

  • Hodgkin's Disease

Interventions

PROCEDURE

Pulmonary Function Tests

Tests include; total lung capacity, vital capacity, functional residual capacity, forced vital capacity, forced expiratory volume in 1 second, carbon monoxide diffusing capacity, pulse oximetry before and after a 6 minute walk and Pulmonary Status and Dyspnea Questionnaire

PROCEDURE

CAT Scan

Obtained at different time points during the study depending upon standard of care chemotherapy treatment

Sponsors & Collaborators

Principal Investigators

  • Andrea K. Ng, MD, MPH · Dana-Farber Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2005-11-30
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00165438 on ClinicalTrials.gov